Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1992 Jan;66(1):217–225. doi: 10.1128/jvi.66.1.217-225.1992

Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses.

M Rodriguez 1, R P Roos 1
PMCID: PMC238278  PMID: 1727485

Abstract

Intratypic recombinant Theiler's viruses prepared between GDVII and DA strains were used to identify genomic sequences important in neurovirulence, virus persistence, and demyelination and to clarify the mechanisms involved in disease induction. The coding region between 1B and 2C of the highly virulent GDVII strain contains a determinant partly responsible for neurovirulence (early paralysis and death) which correlates with elevated levels of infectious virus and the presence of virus antigen within neurons of the brain stem and gray matter of the spinal cord. Both the GDVII and the DA strains of virus contain genetic determinants for late demyelination in spinal cord. However, quantitative analysis of demyelination produced by recombinant GDVII/DA viruses suggest that multiple gene segments influence the number and extent of demyelinating lesions.

Full text

PDF
217

Images in this article

220Image
on p.220
222Image
on p.222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calenoff M. A., Faaberg K. S., Lipton H. L. Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. Proc Natl Acad Sci U S A. 1990 Feb;87(3):978–982. doi: 10.1073/pnas.87.3.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DANIELS J. B., PAPPENHEIMER A. M., RICHARDSON S. Observations on encephalomyelitis of mice (DA strain). J Exp Med. 1952 Dec;96(6):517–530. doi: 10.1084/jem.96.6.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Friedmann A., Lipton H. L. Replication of Theiler's murine encephalomyelitis viruses in BHK21 cells: an electron microscopic study. Virology. 1980 Mar;101(2):389–398. doi: 10.1016/0042-6822(80)90452-3. [DOI] [PubMed] [Google Scholar]
  4. Fu J. L., Stein S., Rosenstein L., Bodwell T., Routbort M., Semler B. L., Roos R. P. Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4125–4129. doi: 10.1073/pnas.87.11.4125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fu J., Rodriguez M., Roos R. P. Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol. 1990 Dec;64(12):6345–6348. doi: 10.1128/jvi.64.12.6345-6348.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kong W. P., Roos R. P. Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J Virol. 1991 Jun;65(6):3395–3399. doi: 10.1128/jvi.65.6.3395-3399.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lipton H. L., Dal Canto M. C. The TO strains of Theiler's viruses cause "slow virus-like" infections in mice. Ann Neurol. 1979 Jul;6(1):25–28. doi: 10.1002/ana.410060106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Liu C., Collins J., Sharp E. The pathogenesis of Theiler's GD VII encephalomyelitis virus infection in mice as studied by immunofluorescent technique and infectivity titrations. J Immunol. 1967 Jan;98(1):46–55. [PubMed] [Google Scholar]
  9. Lorch Y., Friedmann A., Lipton H. L., Kotler M. Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically. J Virol. 1981 Nov;40(2):560–567. doi: 10.1128/jvi.40.2.560-567.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McAllister A., Tangy F., Aubert C., Brahic M. Genetic mapping of the ability of Theiler's virus to persist and demyelinate. J Virol. 1990 Sep;64(9):4252–4257. doi: 10.1128/jvi.64.9.4252-4257.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McAllister A., Tangy F., Aubert C., Brahic M. Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts. Microb Pathog. 1989 Nov;7(5):381–388. doi: 10.1016/0882-4010(89)90041-7. [DOI] [PubMed] [Google Scholar]
  12. Nitayaphan S., Toth M. M., Roos R. P. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses. J Virol. 1985 Feb;53(2):651–657. doi: 10.1128/jvi.53.2.651-657.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ohara Y., Senkowski A., Fu J. L., Klaman L., Goodall J., Toth M., Roos R. P. Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses. J Virol. 1988 Sep;62(9):3527–3529. doi: 10.1128/jvi.62.9.3527-3529.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ohara Y., Stein S., Fu J. L., Stillman L., Klaman L., Roos R. P. Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology. 1988 May;164(1):245–255. doi: 10.1016/0042-6822(88)90642-3. [DOI] [PubMed] [Google Scholar]
  15. Oleszak E. L., Leibowitz J. L., Rodriguez M. Isolation and characterization of two plaque size variants of Theiler's murine encephalomyelitis virus (DA strain). J Gen Virol. 1988 Sep;69(Pt 9):2413–2418. doi: 10.1099/0022-1317-69-9-2413. [DOI] [PubMed] [Google Scholar]
  16. Patick A. K., Oleszak E. L., Leibowitz J. L., Rodriguez M. Persistent infection of a glioma cell line generates a Theiler's virus variant which fails to induce demyelinating disease in SJL/J mice. J Gen Virol. 1990 Sep;71(Pt 9):2123–2132. doi: 10.1099/0022-1317-71-9-2123. [DOI] [PubMed] [Google Scholar]
  17. Pevear D. C., Borkowski J., Calenoff M., Oh C. K., Ostrowski B., Lipton H. L. Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology. 1988 Jul;165(1):1–12. doi: 10.1016/0042-6822(88)90652-6. [DOI] [PubMed] [Google Scholar]
  18. Pevear D. C., Calenoff M., Rozhon E., Lipton H. L. Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol. 1987 May;61(5):1507–1516. doi: 10.1128/jvi.61.5.1507-1516.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rodriguez M., Leibowitz J. L., Lampert P. W. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol. 1983 Apr;13(4):426–433. doi: 10.1002/ana.410130409. [DOI] [PubMed] [Google Scholar]
  20. Rodriguez M., Oleszak E., Leibowitz J. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol. 1987;7(4):325–365. [PubMed] [Google Scholar]
  21. Rodriguez M., Sriram S. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J Immunol. 1988 May 1;140(9):2950–2955. [PubMed] [Google Scholar]
  22. Roos R. P., Kong W. P., Semler B. L. Polyprotein processing of Theiler's murine encephalomyelitis virus. J Virol. 1989 Dec;63(12):5344–5353. doi: 10.1128/jvi.63.12.5344-5353.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Roos R. P., Richards O. C., Ehrenfeld E. Analysis of Theiler's virus isolates from persistently infected mouse nervous tissue. J Gen Virol. 1983 Mar;64(Pt 3):701–706. doi: 10.1099/0022-1317-64-3-701. [DOI] [PubMed] [Google Scholar]
  24. Roos R. P., Stein S., Ohara Y., Fu J. L., Semler B. L. Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J Virol. 1989 Dec;63(12):5492–5496. doi: 10.1128/jvi.63.12.5492-5496.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Roos R. P., Stein S., Routbort M., Senkowski A., Bodwell T., Wollmann R. Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. J Virol. 1989 Oct;63(10):4469–4473. doi: 10.1128/jvi.63.10.4469-4473.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tangy F., McAllister A., Aubert C., Brahic M. Determinants of persistence and demyelination of the DA strain of Theiler's virus are found only in the VP1 gene. J Virol. 1991 Mar;65(3):1616–1618. doi: 10.1128/jvi.65.3.1616-1618.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tangy F., McAllister A., Brahic M. Molecular cloning of the complete genome of strain GDVII of Theiler's virus and production of infectious transcripts. J Virol. 1989 Mar;63(3):1101–1106. doi: 10.1128/jvi.63.3.1101-1106.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Theiler M. SPONTANEOUS ENCEPHALOMYELITIS OF MICE--A NEW VIRUS DISEASE. Science. 1934 Aug 3;80(2066):122–122. doi: 10.1126/science.80.2066.122-a. [DOI] [PubMed] [Google Scholar]
  29. Zurbriggen A., Fujinami R. S. A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system. J Virol. 1989 Apr;63(4):1505–1513. doi: 10.1128/jvi.63.4.1505-1513.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Zurbriggen A., Hogle J. M., Fujinami R. S. Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med. 1989 Dec 1;170(6):2037–2049. doi: 10.1084/jem.170.6.2037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Zurbriggen A., Thomas C., Yamada M., Roos R. P., Fujinami R. S. Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol. 1991 Apr;65(4):1929–1937. doi: 10.1128/jvi.65.4.1929-1937.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES